The work of NHS Diabetes has now come to a close and responsibility for this website has transferred to NHS Improving Quality (NHS IQ). Content on this site will remain accessible for up to three months from 1 April 2013 but the site will no longer be regularly updated. For further information or enquiries, please contact enquiries@nhsiq.nhs.uk

NHS

Ask a question

As of April 1st 2013 NHS Diabetes became part of NHS Improving Quality. Please direct your enquiry to enquiries@nhsiq.nhs.uk

News archive

News and events3 Sept

Overdose drug may help diabetes patients, UHI researchers say

New research could offer help to people with type 2 diabetes.

It suggests a drug used for reversing the effects of paracetamol overdose has the potential to reduce the risk of heart disease in the patients.

The discovery was made by a team led by Prof Ian Megson at the University of the Highlands and Island's Department of Diabetes and Cardiovascular Science.

The Inverness team's study of the drug N-acetylcysteine was funded by the Chief Scientist Office.

Heart disease is a major cause of reduced life expectancy in patients with diabetes.

Aspirin, the drug normally used to prevent heart attacks, is less effective for people with diabetes before heart disease has been diagnosed, UHI said.

Prof Megson's team looked at N-acetylcysteine's effects on blood platelets, a key component of blood clots.

The clots play a part in causing heart attacks and some forms of stroke.

Blood platelets in people with type 2 diabetes have depleted reserves of an antioxidant called glutathione.

The UHI researchers found that once daily treatment of N-acetylcysteine brought platelet glutathione back to normal and reduced indicators of clot formation in the blood.

Potentially, the licensed drug could be used before heart damage is diagnosed.

The work has been published in the journal Diabetologia.

For more on this story see the BBC News website.

Bookmark and Share